spacer image
Skip Nav Skip to Search
Contact
spacer image
get adobe reader

Announcements
white mail envelope

Sign
up for Announcement alerts

May 14, 2015

DEA Pharmacy Diversion Awareness Conference (click to view) - Designed for Pharmacists, Pharmacy Technicians and Loss Prevention Personnel.  Conference is Saturday, June 27, 2015 or Sunday, June 28, 2015 in Oklahoma City.  Continuing Education credit is available for Pharmacists and Pharmacy Technicians.  View flyer for more information. 

May 12, 2015

FRAUDULENT PRESCRIPTION FORM (click to view) - In an effort to reduce prescription fraud and abuse, the Oklahoma Bureau of Narcotics and Dangerous Drugs (OBNDD) has provided an avenue to report fraudulent prescriptions to their Compliance Division.  If you would like to report a fraudulent prescription to the OBNDD, please complete this form and fax it to the phone number provided.  A link to this form is also available under "Related Links".

April 21, 2015

Congratulations! Eighty-seven (87) pharmacists were issued an Oklahoma Doctor of Pharmacy license during the period from January -  March 2015 (click here to view).

April 21, 2015

OSBP-ISMP Pharmacy Practice Safety Conference 2015 - The Oklahoma State Board of Pharmacy will be hosting a half-day continuing education conference aimed at improving patient safety for pharmacists.  Two locations are being offered this year:  Oklahoma City, OK on June 23rd or Tulsa, OK on June 24th.  

The conference, including lunch and three (3) hours of ACPE-accredited continuing education, is being provided without charge by the Board to further its mission of protecting the health, safety and welfare of the citizens of Oklahoma.

Donna Horn, R.Ph., D.Ph., Director, Patient Safety-Community Pharmacy from the Institute for Safe Medication Practices (ISMP) will present three (3) hours of ACPE-accredited CE on the topics of: 1) Rooting Out Errors in Your Pharmacy - 2 hours 2) There Seems to Be a Mistake With My Prescription (An ambulatory approach to responding to a medication error) - 1 hour.

The programs will be the same for each day. No duplicate registrations are allowed. 

Tuesday, June 23, 2015 Oklahoma Sports Hall of Fame Event Center 4040 N Lincoln Blvd Oklahoma City, OK

Wednesday, June 24, 2015 Renaissance Hotel & Convention Center 6808 S 107th E Ave Tulsa, OK

Sign-In  11:00 am - 12:00 pm

Lunch (no cost- included with free registration) 12:00 pm - 1:00 pm

Program 1:00 pm - 4:30 pm

REGISTRATION: Reservations will be accepted on a first-come basis. Email the following information to sdozal@pharmacy.ok.gov to reserve a spot:

    • Seminar Location you wish to attend
    • Full Name
    • OK DPh License #
    • NABP e-Profile ID #
    • Birth Month
    • Birth Day
    • Email
    • Phone

View Conference Flyer:

OSBP-ISMP Pharmacy Practice Safety Conference 2015

January 2, 2015

Congratulations! Forty-eight (48) pharmacists were issued an Oklahoma Doctor of Pharmacy license during the period from November - December 2014 (click here to view).

December 5, 2014

OPTOMETRIST RX'S FOR HYDROCODONE CONTAINING MEDICATIONS:
Oklahoma pharmacies my fill prescriptions written by doctors of optometry (optometrists) for Hydrocodone containing medications for up to a 5 day supply by virtue of a state law which went into effect November 1, 2014.

59 OS Sect 581 (B). The practice of optometry shall also include the prescribing of dangerous drugs and controlled dangerous substances for all schedules specified in the Uniform Controlled Dangerous Substances Act except Schedules I and II but allowing for the prescribing of hydrocodone or hydrocodone-containing drugs regardless of schedule for a period not exceeding five (5) days of supply, and the issuance of refills for such prescriptions following sufficient physical examination of the patient for the purpose of diagnosis and treatment of ocular abnormalities. The practice of optometry shall not include the dispensing of drugs but may include the dispensing of professional samples to patients. 

November 4, 2014

E-PRESCRIBING OF CDS:
E-Prescribing of CII and CIII-V is permitted as long as the pharmacy and prescriber are EPCS (E-Prescribing of Controlled Substances) certified.  A pharmacy whose software is EPCS certified will recognize other EPCS certified software and will accept CDS prescriptions from those prescribers who are also EPCS certified or reject those who are not.

Faxed prescriptions are not the same as electronic prescriptions.  Faxed or written CDS prescriptions must bear the manual signature of the prescriber.  They cannot bear a stamped, computer-generated signature, or “electronic signature on file”. 
C-II prescriptions may not be faxed except under the exceptions allowed for hospice and LTCF patients. Please see OAC 475:30-1-4(f)(3) for complete rules.

October 2, 2014

NATIONAL TRANSPORTATION SAFETY BOARD (NTSB) ANNOUNCEMENT (click to view):  On September 23, 2014, the NTSB issued a Safety Recommendation highlighting the importance of licensed health care providers and pharmacists routinely discussing with patients the effect their diagnosed medical conditions or recommended drugs may have on their ability to safely operate a vehicle in any mode of transportation.

August 28, 2014

NOTICE OF HYDROCODONE RESCHEDULE EFFECTIVE OCTOBER 6, 2014 (click to view):  All products containing Hydrocodone will be rescheduled as a Schedule II (C-II) beginning October 6, 2014.  To make the transition easier, the Board, working with multiple agencies, has summarized the essential information pertaining to the change.  This summary is designed for the convenience of both pharmacists and practitioners and should be shared as necessary. Pharmacists should make an effort to share with all pharmacy staff.

August 5, 2014

TRAMADOL UPDATE: Tramadol will become a federally controlled Schedule IV beginning August 18, 2014.  Though Tramadol has been a controlled substance in the State of Oklahoma since November 1, 2012, the DEA is requiring that pharmacies take an inventory of all Tramadol and Tramadol-containing products on AUGUST 18, 2014.  The inventory must be kept on file in the pharmacy.

August 5, 2014

Congratulations!  Eighty-six (86) pharmacists were issued an Oklahoma Doctor of Pharmacy license during the period from May - July 2014 (click here to view).

May 27, 2014

NOTICE OF PARENTERAL PERMIT & PHARMACIST-IN-CHARGE REQUIREMENTS FOR LICENSED NON-RESIDENT PHARMACIES (click to view Board memo) 

Beginning July 1, 2014 there will be a change in the licensing requirements for non-resident pharmacies licensed by the Board that are compounding sterile drug products.  If a licensed non-resident pharmacy is compounding sterile drug products, they must obtain an Oklahoma "Parenteral Permit" in addition to their pharmacy license.

Beginning January 1, 2015 all new and renewal non-resident pharmacy license applications that require a parenteral permit (i.e. pharmacies compounding sterile drug products) will also be required to have an Oklahoma license pharmacy manager or pharmacist-in-charge.

August 14, 2012

PSE questions & answers for pharmacies selling PSE. (click to view)

October 6, 2010

DEA Policy Statement on Role of Agents in Communicating CS Prescriptions:
Drug Enforcement Administration (DEA) issued a statement of policy that clarifies the proper role of a duly authorized agent of a DEA-registered individual practitioner in communicating controlled substance (CS) prescription information to a pharmacy. The statement, published October 6, 2010, in the Federal Register, reminds health care providers that a prescription for a CS medication must be issued by a DEA-registered practitioner acting in the usual course of professional practice. Such a practitioner may authorize an agent to “perform a limited role in communicating such prescriptions to a pharmacy in order to make the prescription process more efficient,” and the guidance emphasizes that medical determinations to prescribe CS medications may be made by the practitioner only. The specific circumstances in which an agent may assist in communicating prescription information to a pharmacy are detailed and include:
♦♦ An authorized agent may prepare the prescription, based on the instructions of the prescribing practitioner, for the signature of that DEA-registered practitioner.
♦♦ For a Schedule III-V drug, an authorized agent may transmit a practitioner-signed prescription to a pharmacy via facsimile, or may communicate the prescription orally to a pharmacy on behalf of the practitioner.
♦♦ An authorized agent may transmit by facsimile a practitioner signed Schedule II prescription for a patient in a hospice or long-term care facility (LTCF) on behalf of the practitioner.
The guidance also makes clear that generally, Schedule II prescriptions may not be transmitted by facsimile and that hospice and LTCFs are exceptions. Further,Schedule II prescriptions may only be communicated orally by the DEA-registered practitioner and only in emergency situations. DEA stresses that the practitioner should decide who may act as his or her authorized agent and advises that such designation be established in writing. An example written agreement is included in the policy statement, along with additional guidance related to designating an authorized agent. DEA also notes that as electronic prescribing for CS is implemented and its use increases, the role of the agent in communicating CS prescriptions will likely be reduced over time. The DEA policy statement is available on the
Federal Register Web site at www.federalregister.gov/articles/2010/10/06/2010-25136/roleof-authorized-agents-in-communicating-controlled-substanceprescriptions-to-pharmacies.

July 2, 2009

EFFECTIVE IMMEDIATELY the following ID's are allowed in Oklahoma for PSE:

State Issued Driver's License
State Issued ID Card
Military ID
Passport

If, and only if, a patient has none of these types of ID, such as a nursing home patient, then you may use a social security number to submit for PSE and PMP.  For the purpose of accepting ID’s, please refer to the following definition:  “State” means any state, territory, or possession of the United States, the District of Columbia, or foreign nation.

Any questions concerning PSE requirements should be directed to the Oklahoma Bureau of Narcotics at 405-521-2885.

 

Last Modified on 05/14/2015
Related Topics